Font Size: a A A
Keyword [large B-cell lymphoma]
Result: 181 - 200 | Page: 10 of 10
181. Expression Of HIP1R And FOXP1 In Diffuse Large B-Cell Lymphoma And Its Relationship With Prognosis
182. Analysis Of Predicting Efficiency Of NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma
183. CD 10, BCL-6, MUM-1 And BCL-2 Expression In Diffuse Large B Cell Lymphoma And Its Relationship With Prognosis
184. To Investigate The MicroRNA Expression Profile In Diffuse Large B-cell Lymphoma
185. Prognostic Factors Analysis Of 59 Patients With Diffuse Large B-cell Lymphoma
186. A Case Report Of Primary Gastric Malignant Lymphoma And Literature Review
187. Expression And Function Of MicroRNA-29b In Diffuse Large B-cell Lumphoma
188. Expression And Significance Of IL-12 In Classical Hodgkin Lymphoma And Diffuse Large B-cell Lymphoma
189. Expression Of Has-miR-339-3p And Has-miR-339-5p In Diffuse Large B_cell Lymphoma And Its Significance
190. Clinical Pathological Features And Analysis Of 179 Caseswith Diffuse Large B Cell Lymphoma(DLBCL)
191. Clinical Study Of Young Patients With High Risk Diffuse Large B-Cell Lymphoma(DLBCL)
192. Clinical And Pathological Characteristics Of De Novo DLBCLs With Decreased CD20 Cell Surface Expression
193. Structure Aberration Of MYC Gene And Regulation Of MYC Protein By BCR Signaling In Diffuse Large B-cell Lymphoma
194. Loss Of IRF8 Inhibits The Growth Of Diffuse Large B-cell Lymphoma
195. Efficacy Analysis On Rituximab Combined With Chemotherapy In The Treatment Of Diffuse Large B-cell Lymphoma And Bcl-2 Protein Overexpression
196. Inhibition Of Indoleamine 2, 3-Dioxygenase In CD20+ Diffuse Large B Cell Lymphoma Cell Correlates With Rituximab-mediated Antibody-dependent Cell-mediated Cytotoxicity
197. The Relationship Between CD10, Bcl-6, VEGF With The Prognosis In The Primary Gastrointestinal Diffuse Large B-cell Lymphoma
198. Prognostic Significance Of Immunohistochemical Markers In Patients With Diffuse Large B Cell Lymphoma: A Clinical Study On Prognostic Impact Of Rituximab On Immunohistochemical Markers
199. Expression And Clinical Significance Of MiR-155、miR-15a、miR-16-1 In Patients With Diffuse Large B-cell Lymphoma
200. Study Of 18F-FDG PET/CT In The Diagnosis Of Diffuse Large B Cell Lymphoma Chemotherapy Interim And Curative Effect Evaluation
  <<First  <Prev  Next>  Last>>  Jump to